Welcome to the Sunday Discussion segment! Each week here on Geek Alabama, Sunday Discussion will feature a serious topic that needs to be featured and talked about. You can “discuss” it on your own social media networks as comments are banned here on Geek Alabama.

Pharmaceutical giant, Novo Nordisk, is now Europe’s most valuable company, worth more than its home country, Denmark’s total economy. That wasn’t always the case, and only recently, through its popular diabetes and weight-loss drugs, Ozempic and Wegovy, is it witnessing unprecedented financial success. For a century, the company predominantly focused on insulin and treating those with Type 2 diabetes. In its 2023 second quarter, the company reported a 46% increase in net profits and a 32% increase in sales compared to the same quarter the year prior. Alongside competitors like Eli Lilly the company is hoping to help treat the 1 billion people worldwide who are affected by obesity and hence transform a largely untapped market.

Liked it? Take a second to support Geek Alabama on Patreon!

Sunday Discussion: How The Olympics Became So Expensive For Host Cities Sunday Discussion: Why U.S. Ports Are Some Of The Least Efficient In The World Sunday Discussion: Why Atlanta Became A Political Powerhouse